Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn

 
• By Jessica Merrill

Industry leaders and experts at the Financial Times Pharma and Biotech Summit said the US relationship with China adds pressing risk to pharma.

US-China
Geopolitics, especially the US-China relationship, are a growing risk for pharma, Biogen CEO Chris Viehbacher said. • Source: Shutterstock

More from Legislation

More from Pink Sheet